GlassScriptPhysician profile
Harvey Dubiner
NPI 1306830807
$30,821.78
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $57.54.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $21,407.63 | 2019-2020 | |
| Aerie Pharmaceuticals, INC. | $7,690.04 | 2019 | |
| Perrigo Company Plc | $1,468.57 | 2019 | |
| Novartis Pharmaceuticals Corporation | $135.18 | 2019 | |
| Dompe US, INC. | $45.79 | 2019 | |
| Ocular Therapeutix, INC. | $23.64 | 2019 | |
| Eyevance Pharmaceuticals LLC | $18.92 | 2019 | |
| Kala Pharmaceuticals, INC. | $17.59 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $14.42 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Research and ownership
$49,250.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harvey Dubiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.